MARKET

SYK

SYK

Stryker Corp
NYSE
275.56
+5.55
+2.06%
After Hours: 276.93 +1.37 +0.50% 19:49 09/11 EDT
OPEN
270.72
PREV CLOSE
270.01
HIGH
277.00
LOW
267.00
VOLUME
3.72M
TURNOVER
--
52 WEEK HIGH
391.91
52 WEEK LOW
267.00
MARKET CAP
105.70B
P/E (TTM)
28.55
1D
5D
1M
3M
1Y
5Y
1D
Stryker (SYK) Could Be 13% Undervalued After Cyberattack And Vision Pro Milestone
Simply Wall St · 2d ago
Boston Scientific Corp. Stock Falls 4.1%, Underperforms Peers
Dow Jones · 2d ago
Stryker Is Maintained at Buy by Citigroup
Dow Jones · 2d ago
Stryker Price Target Cut to $360.00/Share From $399.00 by Citigroup
Dow Jones · 2d ago
Citigroup Maintains Buy on Stryker, Lowers Price Target to $360
Benzinga · 2d ago
Stryker price target lowered to $360 from $399 at Citi
TipRanks · 3d ago
Securities Fraud Investigation Into Stryker Corporation (SYK) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Barchart · 3d ago
Stryker (SYK) Faces Investigation Over Peripheral Vascular Manufacturing Disclosures
Simply Wall St · 3d ago
More
About SYK
Stryker Corporation is a medical technology company. It offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics primarily include implants used in total joint replacements, such as hip, knee and shoulder, and others. It offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs. It is also focused on treating calcified arterial disease.

Webull offers Stryker Corp stock information, including NYSE: SYK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SYK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SYK stock methods without spending real money on the virtual paper trading platform.